Close Menu

NEW YORK – The GenomeWeb Index rose nearly 13 percent in July, as investors once again sought to reward companies that seemed to be making significant developments with their SARS-CoV-2 diagnostics.

The index outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which rose 2 percent, 7 percent, and nearly 2 percent, respectively. Individual stock performances in the GenomeWeb Index were overwhelmingly positive in July, as 28 of the 32 stocks saw gains and only four saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.